In contrast, the increased expression of ALKBH5 promoted m6A demethylation and the stability of GLUT4 mRNA in a YTHDF2-dependent manner, which resulted in enhanced glycolysis in drug-resistant breast cancer cells [33]. This evidence concerns the gene ALKBH5 and breast carcinoma.